Treating Bacterial Overgrowth in Parkinson's Disease

NCT02470780 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease
Small Intestinal Bacterial Overgrowth

Interventions

DRUG: Rifaximin
DRUG: Placebo

Sponsor

University of Cincinnati